120 related articles for article (PubMed ID: 12224487)
1. [Biological variables and stratification of patients with inoperable non-small-cell bronchial cancer: recommendations for future trials].
Watine J; Friedberg B; Bouarioua N
Cancer Radiother; 2002 Jun; 6(4):209-16. PubMed ID: 12224487
[TBL] [Abstract][Full Text] [Related]
2. Are laboratory investigations recommended in current medical practice guidelines supported by available evidence?
Watine J
Clin Chem Lab Med; 2002 Mar; 40(3):252-5. PubMed ID: 12005215
[TBL] [Abstract][Full Text] [Related]
3. [Laboratory variables and stratification of small-cell lung cancer patients: recommendations for therapeutic trials and for clinical practice guidelines].
Watine J; Friedberg B; Charet JC
Ann Biol Clin (Paris); 2004; 62(2):189-96. PubMed ID: 15047471
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors of tumor response and prognostic factors of survival during lung cancer chemotherapy.
Ray P; Quantin X; Grenìer J; Pujol JL
Cancer Detect Prev; 1998; 22(4):293-304. PubMed ID: 9674872
[TBL] [Abstract][Full Text] [Related]
5. Laboratory variables and stratification of metastatic colorectal cancer patients: recommendations for therapeutic trials and for clinical practice guidelines.
Watine J; Friedberg B
Clin Chim Acta; 2004 Jul; 345(1-2):1-15. PubMed ID: 15193973
[TBL] [Abstract][Full Text] [Related]
6. [Unresected colorectal liver metastases: prognostic value of laboratory variables].
Friedberg B; Watine J; Miédougé M
Gastroenterol Clin Biol; 2001 Nov; 25(11):962-6. PubMed ID: 11845046
[TBL] [Abstract][Full Text] [Related]
7. Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients.
Pujol JL; Boher JM; Grenier J; Quantin X
Lung Cancer; 2001; 31(2-3):221-31. PubMed ID: 11165401
[TBL] [Abstract][Full Text] [Related]
8. Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.
van Zandwijk N; Jassem E; Bonfrer JM; Mooi WJ; van Tinteren H
Semin Oncol; 1992 Feb; 19(1 Suppl 2):37-43. PubMed ID: 1329221
[TBL] [Abstract][Full Text] [Related]
9. Neuron specific enolase and prognosis of non-small cell lung cancer: a systematic review and meta-analysis.
Yan HJ; Tan Y; Gu W
J BUON; 2014; 19(1):153-6. PubMed ID: 24659657
[TBL] [Abstract][Full Text] [Related]
10. The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: a systematic review and meta-analysis.
Huang Y; Wei S; Jiang N; Zhang L; Wang S; Cao X; Zhao Y; Wang P
BMC Cancer; 2018 Dec; 18(1):1235. PubMed ID: 30526532
[TBL] [Abstract][Full Text] [Related]
11. Serum vascular endothelial growth factor levels correlate better with tumour stage in small cell lung cancer than albumin, neuron-specific enolase or lactate dehydrogenase.
Mall JW; Schwenk W; Philipp AW; Meyer-Kipker C; Mall W; Muller J; Pollmann C
Respirology; 2002 Jun; 7(2):99-102. PubMed ID: 11985730
[TBL] [Abstract][Full Text] [Related]
12. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer.
Foa P; Fornier M; Miceli R; Seregni E; Santambrogio L; Nosotti M; Cataldo I; Sala M; Caldiera S; Bombardieri E
Anticancer Res; 1999; 19(4C):3613-8. PubMed ID: 10629660
[TBL] [Abstract][Full Text] [Related]
13. Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC).
Jørgensen LG; Osterlind K; Hansen HH; Cooper EH
Br J Cancer; 1994 Oct; 70(4):759-61. PubMed ID: 7917935
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer.
Imai H; Kaira K; Mori K; Ono A; Akamatsu H; Matsumoto S; Taira T; Kenmotsu H; Harada H; Naito T; Murakami H; Endo M; Nakajima T; Yamada M; Takahashi T
BMC Cancer; 2015 Dec; 15():989. PubMed ID: 26690494
[TBL] [Abstract][Full Text] [Related]
15. [Elevated serum NSE level in locally advanced and metastatic NSCLC predispose to better response to chemotherapy but worse survival].
Załeska M; Szturmowicz M; Zych J; Roszkowska-Sliz B; Demkow U; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2010; 78(1):14-20. PubMed ID: 20162514
[TBL] [Abstract][Full Text] [Related]
16. [Significance of serum neuron-specific enolase before treatment in predicting brain metastases and prognosis of advanced non-small cell lung cancer].
Chen Y; Peng W; Huang Y; Chen J; Su G; Jiang C; Xiao Y
Zhonghua Zhong Liu Za Zhi; 2015 Jul; 37(7):508-11. PubMed ID: 26463326
[TBL] [Abstract][Full Text] [Related]
17. Discriminant analysis on small cell lung cancer and non-small cell lung cancer by means of NSE and CYFRA-21.1.
Paone G; De Angelis G; Munno R; Pallotta G; Bigioni D; Saltini C; Bisetti A; Ameglio F
Eur Respir J; 1995 Jul; 8(7):1136-40. PubMed ID: 7589398
[TBL] [Abstract][Full Text] [Related]
18. [Bibliographic analysis of the use of laboratory blood parameters for the prognosis of primary lung cancer].
Watine J; Rouzaud P; Charet JC
Ann Biol Clin (Paris); 1999; 57(1):57-68. PubMed ID: 9920968
[TBL] [Abstract][Full Text] [Related]
19. Prediction of lung cancer based on serum biomarkers by gene expression programming methods.
Yu Z; Chen XZ; Cui LH; Si HZ; Lu HJ; Liu SH
Asian Pac J Cancer Prev; 2014; 15(21):9367-73. PubMed ID: 25422226
[TBL] [Abstract][Full Text] [Related]
20. The prognostic influence of serum neuron specific enolase in small cell lung cancer.
Jørgensen LG; Osterlind K; Hansen HH; Cooper EH
Br J Cancer; 1988 Dec; 58(6):805-7. PubMed ID: 2852029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
